The PREP Act and COVID-19, part 1 : statutory authority to limit liability for medical countermeasures /
| Main Author: | Hickey, Kevin J. (Author) |
|---|---|
| Format: | Government Document Database |
| Language: | English |
| Published: |
[Washington, D.C.] :
Congressional Research Service,
2020-
|
| Edition: | [Library of Congress public edition]. |
| Series: | Legal sidebar ;
LSB10443. |
| Subjects: | |
| Online Access: | https://purl.fdlp.gov/GPO/gpo152178 |
Similar Items
COVID-19 clinical trials of malaria drugs combined with the antibiotic azithromycin are underway.
Published: (2020)
Published: (2020)
Experimental COVID-19 treatment is studied in remdesivir drug trial at Saint Louis University.
Published: (2020)
Published: (2020)
The urgent need for a national plan to contain the coronavirus : hearing before the Select Subcommittee on the Coronavirus Crisis of the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session, July 31, 2020.
Published: (2020)
Published: (2020)
COVID-19 treatments and therapeutics.
Symptoms and transmission of SARS-CoV-2 among children /
Published: (2020)
Published: (2020)
Biomedical innovations to combat COVID-19 /
Published: (2022)
Published: (2022)
Leveraging technology as a response to the COVID pandemic adapting diverse technologies, workflow, and processes to optimize integrated clinical management /
Published: (2022)
Published: (2022)
COVID-19 : remdesivir for hospitalized adults - a living review.
Published: (2021)
Published: (2021)
COVID-19 testing.
Published: (2020)
Published: (2020)
Textbook of SARS-CoV-2 and COVID-19 : epidemiology, pathophysiology, immunology, clinical manifestations, treatment, complications, and preventive measures /
Published: (2024)
Published: (2024)
Stem cells : an alternative therapy for covid-19 and cytokine storm /
Published: (2024)
Published: (2024)
Development and regulation of medical countermeasures for COVID-19 (vaccines, diagnostics, and treatments) : frequently asked questions /
by: Dabrowska, Agata
Published: (2020)
by: Dabrowska, Agata
Published: (2020)
COVID-19: critical vaccine distribution, supply chain, program integrity, and other challenges require focused federal attention : report to congressional committees.
Published: (2021)
Published: (2021)
New drug for COVID-19 treatment is developed in St. Louis with clinical trial in Kansas.
Published: (2020)
Published: (2020)
COVID-19 : turning the tide.
Published: (2020)
Published: (2020)
SARS-CoV-2 positivity rates among children of racial and ethnic minority groups in Mississippi /
Published: (2020)
Published: (2020)
Covid-19 : the essentials of prevention and treatment /
by: Qu, Jie-Ming
Published: (2021)
by: Qu, Jie-Ming
Published: (2021)
Hybrid hearing with Secretary of Health and Human Services Alex M. Azar II : hearing before the Select Subcommittee on the Coronavirus Crisis of the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session, October 2, 2020.
Published: (2020)
Published: (2020)
Clinical trials of monoclonal antibodies to treat and prevent COVID-19 at Washington University.
Published: (2020)
Published: (2020)
How to create valid, reliable and actionable metrics in the fight against COVID-19.
Published: (2021)
Published: (2021)
COVID-19 vaccine development.
Published: (2020)
Published: (2020)
Coronavirus drug discovery : SARS-CoV-2 (Covid 19) prevention, diagnosis, and treatment.
by: Egbuna, Chukwuebuka
Published: (2022)
by: Egbuna, Chukwuebuka
Published: (2022)
On the front line: how governors are battling the COVID-19 pandemic : virtual hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, second session, June 2, 2020.
Published: (2021)
Published: (2021)
PBS NewsHour.
Published: (2020)
Published: (2020)
Stronger : the battle against COVID-19 /
Published: (2020)
Published: (2020)
Economist video. how dangerous is Omicron? /
Published: (2021)
Published: (2021)
Overview of R0 and vaccine coverage required for COVID-19 herd immunity.
Published: (2020)
Published: (2020)
COVID-19 clinical trial combines remdesivir with anti-inflammatory drug for one-two punch at SLU.
Published: (2020)
Published: (2020)
Neurological care and the COVID-19 pandemic /
Published: (2021)
Published: (2021)
Herd immunity for COVID-19.
Published: (2020)
Published: (2020)
Coping after COVID-19 : cognitive behavioral skills for anxiety, depression, and adjusting to chronic illness - client workbook /
by: Jaywant, Abhishek
Published: (2023)
by: Jaywant, Abhishek
Published: (2023)
Coping after COVID-19 : cognitive behavioral skills for anxiety, depression, and adjusting to chronic illness - client workbook /
by: Jaywant, Abhishek
Published: (2023)
by: Jaywant, Abhishek
Published: (2023)
Biomedical research : information on federal contributions to remdesivir: report to congressional committees /
by: Wright, Candice N.
Published: (2021)
by: Wright, Candice N.
Published: (2021)
Race against pandemic /
Published: (2020)
Published: (2020)
Cover smart, do your part, slow the spread /
Published: (2021)
Published: (2021)
Horizon.
Published: (2020)
Published: (2020)
The unequal pandemic : COVID-19 and health inequalities /
by: Bambra, C. (Clare), et al.
Published: (2021)
by: Bambra, C. (Clare), et al.
Published: (2021)
Textbook of SARS-CoV-2 and COVID-19 : epidemiology, pathophysiology, immunology, clinical manifestations, treatment, complications, and preventive measures /
Published: (2024)
Published: (2024)
United States of fear : how America fell victim to a mass delusional psychosis /
by: McDonald, Mark
Published: (2021)
by: McDonald, Mark
Published: (2021)
Alexandria Public Health Department : COVID vaccine initiative.
Published: (2022)
Published: (2022)